PCVX FY 2018 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$8B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$36M

Net Income

-$29M

EPS (Diluted)

$-8.12

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$749,000

Balance Sheet

Total Assets

$71M

Total Liabilities

$129M

Stockholders' Equity

-$58M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$36M	-$18M	-99.3%
Net Income	-$29M	-$17M	-71.0%